29
/pt/
pt
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Criar
Public Timelines
Biblioteca
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Baixar
Export
Criar uma cópia
Incorporar ao site
Editar
Visualizações 303
0
0
asdfg
Criada
Daniel Rossi
⟶ Atualizado 16 out 2017 ⟶
List of edits
Comentários
Eventos
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD